Departamento de Reumatología, Instituto Nacional de Rehabilitación, Ciudad de México, Mexico.
Unidad de Investigación en Epidemiología Clínica, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico.
Arch Osteoporos. 2018 Oct 10;13(1):105. doi: 10.1007/s11657-018-0520-y.
In Mexico, osteoporosis is a public health problem. In this document, the Mexican Association for Bone and Mineral Metabolism defines its position on calcium, vitamin D supplement use, and physical activity as an effective, safe, and cost-effective initiatives to prevent low bone mass.
In Mexico, osteoporosis is a public health problem that is expected to increase in the decades ahead. Generally, modifiable risk factors for bone health are related with lifestyles, especially nutrition and physical activity.
In this position paper, the Mexican Association for Bone and Mineral Metabolism (AMMOM, by its acronym in Spanish), which is a multidisciplinary group of researchers, dietitians, epidemiologists, nurses, and physicians who study bone and related tissues and communicate the best strategies for diagnosis, treatment, and prevention of bone problems, aims to analyze the association between nutrition and bone health, risk behaviors for low bone mass, and the economic impact that prevention of low bone mass represents for the health care system.
Addressing therapeutic management with pharmacological and non-pharmacological approaches, we emphasize the important role the patient plays in the doctor-patient relationship, both in the consulting room and in daily life. Furthermore, the AMMOM defines its position on calcium and vitamin D supplement use as an effective, safe, and cost-effective initiative to prevent low bone mass.
In summary, most research and clinical practice related to osteoporosis have focused on diagnosis and treatment, but general measures for primary prevention based on addressing modifiable risk factors as a public health priority to delay the onset of loss of bone mass have not been considered by Mexican authorities. Consequently, the AMMOM task force also seeks to provide information on concrete actions to prevent low bone mass.
在墨西哥，骨质疏松症是一个公共卫生问题。在本文件中，墨西哥骨代谢协会定义了其在钙、维生素 D 补充剂使用和身体活动方面的立场，认为这些措施是预防低骨量的有效、安全且具有成本效益的举措。
在墨西哥，骨质疏松症是一个公共卫生问题，预计在未来几十年内会增加。一般来说，与生活方式相关的骨骼健康的可改变危险因素，尤其是营养和身体活动。
在这份立场文件中，墨西哥骨代谢协会（AMMOM），这是一个多学科的研究人员、营养师、流行病学家、护士和研究骨骼和相关组织并交流最佳诊断、治疗和预防骨骼问题策略的医生群体，旨在分析营养与骨骼健康之间的关系、低骨量的风险行为，以及预防低骨量对医疗保健系统的经济影响。
通过药物和非药物方法处理治疗管理，我们强调患者在医患关系中的重要作用，无论是在咨询室还是在日常生活中。此外，AMMOM 确定了钙和维生素 D 补充剂使用作为预防低骨量的有效、安全且具有成本效益的举措。
总之，大多数与骨质疏松症相关的研究和临床实践都集中在诊断和治疗上，但作为公共卫生重点的针对可改变风险因素的一般初级预防措施尚未得到墨西哥当局的考虑。因此，AMMOM 工作组还旨在提供有关预防低骨量的具体行动的信息。
